Consequently, the inhibition of HJURP attenuates the cancer cells' properties and increases the survival rate of patients, and thus, HJURP acts as a prognostic marker for several cancers (Kang et al., 2020; Lai et al., 2021). Here, HJURP is linked to cancer.